🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

doi.org/10.1016/S2666-…

Proud to be invited as Keynote speaker to this fabulous and so well-renowned 26th conference in beautiful Firenze. Thanks to Raff and Domenico, two Masters in the field.

Do we need #ArtificialIntelligence for #HeartFailure ? Learn about how to identify and manage #HF patients and to make #clinical #trials more efficient #Today #HeartFailure2024 European Society of Cardiology Harriette Van Spall, MD MPH 🇨🇦 Camille Lavinia Baciu @IcorCat Dan Atar Jean-Luc Vachiery 🫀 European Society of Cardiology News

Next the discussion with Allan Bohm. Does PDE9 actually have an effect? While only 60 patients CARDINAL-HF is the first step to answer this question. It appears that a consistent signal that this treatment may help in #heartfailure 🟢For more research #HeartFailure2024

This was an amazing session with a terrific faculty and audience

Thank you. This was a great learning experience from some of our giants in the field. And such a great interaction with the audience.

Who is it that is going to assess, mentor and choose the winner of this year's #VesaliusInnovationAward? 🔹 Professor Dr. med. Dan Atar 🔹 jignesh bhate, molecularconnections 🔹 @SDawsonBerlin, ScienceOpen 🔹 Daniel Ebneter, @KargerCEO 🔹 Kate Gardner, scientifyRESEARCH.org 🔹 Dr.

Fascinating paper on excess loss of life during the COVID-19 pandemic by country in countries like NZ🇳🇿 and Norway🇳🇴 with radical lock down policies many lives were saved Will be interesting to see if History records this as a major political mistake. doi.org/10.1002/bimj.2…

⚠️Update on #antithrombotic therapy & body mass. A Clinical consensus 📝 of the European Society of Cardiology (Cardiovascular Pharmacotherapy & Thrombosis WG)‼️ #PositionPaper #ACOD #ESC

I was hoping on a new painting entitled “Sunday on the Charles River “ 😀

Elevated #NatriureticPeptides and #troponins are strong predictors of #HF events, but ever wondered if these biomarkers predict worsening cardiac structure & function? We analyzed NT-proBNP, TnT and TnI in a/w serial echo in ~2000 👤 in #ARIC Just published in Circulation 🧵 /5

Thanks again for the invitation to present at the Norwegian Society of Cardiology! Great to see many friends including Jan Otto Beitnes Peder L. Myhre MD, PhD Thor Edvardsen Dan Atar! Looking forward to collaborate on pragmatic RCTs very soon! And look at the beautiful venue for the meeting 👇

Since December 2024, The International Scientific Board of our journal has 17 members! We are honored to announce that new members are: Dan Atar , Boriani Giuseppe , Filippo Crea, Cecilia Linde and Gregory Lip. We hope that their support will enhance the journal's standing!

Congratulations Gabriel! My sincere honor and reverence to your family!

Xavier Rosselló European Society of Cardiology European Society of Cardiology Journals Borja Ibanez Jesús Álvarez-García Prof Chris P Gale Javed Butler John Munkhaugen Dan Atar Gregg W. Stone MD rafavidalperez HU Son Espases IdISBa Hopefully our findings, which would be soon revealed alongside the results of the BETAMI-DANBLOCK trial, will contribute to a level of evidence A of future ACS guidelines! Borja Ibanez Sergio Raposeiras-Roubín JóvenesSEC CVCT - CardioVascular Clinical Trialists Faiez ZANNAD Gregg W. Stone MD Javed Butler Harriette Van Spall, MD MPH 🇨🇦

Enormously honored and proud to present at the famous “Oxford Master Course in Clinical Trials” alongside some of the World’s most famous trialists: Sir Richard Peto, Sir Rory Collins, Professors Colin Baigent, Jane Armitage, Louise Bowman, Amanda Adler, Peter Jüni.

Hard to find a more star-spangled faculty…😊   The European Heart Academy under the ESC is a proud co-sponsor of this postgraduate course.   We look forward to welcoming today’s participants into our EHA-Alumni community once they have graduated.              #ESC

New ESC WG on Thrombosis consensus statement! Antithrombotic therapy in patients with congenital bleeding disorders—balancing thrombotic risk with bleeding management. 📖  tinyurl.com/yc2ahtxk Dan Atar EHJ-CVP Editor-in-Chief #ESCThorombosis

En minneverdig dag den 25/4/2025 med uhyre spennende vitenskapelige diskusjoner i anledning dr. Camilla Settergren sin disputas på Karolinska instituttet. Takk for å få den ærefulle oppgaven som opponent. Gratulerer til kandidaten og hennes 4 enestående veiledere 👏🎼🥂